🔗 Share this article

Chancellor Rachel Reeves has revealed she is planning "specific action to tackle household expense challenges" in next month's Budget.

Speaking to the BBC, she emphasized that reducing inflation is a joint task of both the administration and the central bank.

The UK's inflation rate is projected to be the highest among the Group of Seven industrialized countries this year and the following year.

Potential Utility Cost Measures

It is understood the administration could intervene to lower utility costs, such as by reducing the current 5% rate of VAT charged on energy.

Another approach is to reduce some of the government charges currently included in household expenses.

Fiscal Constraints and Analyst Expectations

The government will obtain the latest draft from the independent fiscal watchdog, the OBR, on the start of the week, which will clarify how much room there is for such actions.

The view from most experts is that the Chancellor will have to introduce higher taxes or spending cuts in order to adhere to her voluntary fiscal targets.

Earlier on Thursday, calculations suggested there was a twenty-two billion pound gap for the Treasury chief to fill, which is at the more modest range of projections.

"It is a shared task between the Bank of England and the administration to further reduce some of the sources of price increases," Reeves told the BBC in the US capital, at the annual meetings of the International Monetary Fund and World Bank.

Revenue Commitments and International Issues

While a great deal of the attention has been on probable tax increases, the Treasury chief said the latest figures from the OBR had not changed her vow to campaign commitments not to raise rates on income tax, sales tax or social security contributions.

She attributed an "unpredictable world" with rising international and trade issues for the Budget tax moves, probably to be focused on those "wealthiest."

International Trade Tensions

Commenting on apprehensions about the UK's trade ties with the Asian nation she said: "Our security interests always come first."

Last week's declaration by China to tighten trade restrictions on critical minerals and other materials that are crucial for advanced tech production led US President Donald Trump to threaten an further 100% import tax on goods from the Asian country, increasing the risk of an full-scale trade war between the two economic giants.

The US Treasury Secretary called China's decision "commercial pressure" and "a global supply chain power grab."

Asked about accepting the American proposal to participate in its dispute with China, the Chancellor said she was "deeply worried" by China's measures and called on the Beijing authorities "to avoid restrictions and limit trade."

She said the move was "bad for the global economy and creates additional challenges."

"I believe there are areas where we must address Chinese policies, but there are also valuable opportunities to sell into China's economy, including financial services and other sectors of the economy. We've got to maintain that equilibrium right."

The chancellor also confirmed she was collaborating with international partners "on our own critical minerals approach, so that we are more independent."

Health Service Medicine Costs and Investment

The Chancellor also admitted that the price the National Health Service spends on pharmaceuticals could go up as a result of current talks with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and capital.

A number of the biggest global drug companies have said recently that they are either delaying or canceling investments in the UK, with several blaming the insufficient payments they are getting.

Recently, the government science advisor said the cost the health service pays for drugs would need to rise to stop businesses and drug research funding departing from the UK.

The Chancellor stated to media: "It has been observed as a result of the pricing regime, that drug testing, recent pharmaceuticals have not been offered in the UK in the manner that they are in other European countries."

"Our aim is to guarantee that individuals receiving treatment from the NHS are can access the finest essential drugs in the world. And so we are looking at all of that, and... looking to secure increased capital into the UK."